Analyst Ratings for Ultragenyx Pharma (RARE) [Buys]
RARE Rating Summary
RARE Price Target Summary
- Highest: $130.00 (Piper Sandler)
- Lowest: $48.00 (Wedbush)
- Average: $91.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$91.14 (+107.9%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
Avg. $ Target:
$91.14 (+107.9%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/22/2024 | RBC Capital | Luca Issi | New Coverage | Outperform (N/A) |
77.00 (N/A) |
43.38 (43.85) |
1.08% | Details |
| 12/8/2023 | Wells Fargo | N/A | New Coverage | Overweight (N/A) |
72.00 (N/A) |
41.11 (43.85) |
6.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
